It has been eight years since weight-loss drug Ozempic hit the market, while Wegovy surfaced in 2021. Since then many reports have been written about the wider health benefits of the so-called wonder drugs.
Ozempic and Wegovy, which contain a medication called semaglutide, are manufactured by Novo Nordisk. Both drugs can be used by those with type 2 diabetes to help aid weight loss and manage blood sugar levels. However, Wegovy has since been approved in the UK to aid weight loss in those without diabetes. Since their launch, the pharma giant has seen a boom in profits, and it isn’t surprising to see why.
Research published this week claimed the drug could slow down ageing and has “far-reaching benefits” beyond what was originally imagined. The studies found those who took the drug died at a lower rate from all causes including cardiovascular diseases and Covid-19. The study covered 17,604 people who were overweight or obese and had an established cardiovascular disease.
Participants were given semaglutide or a placebo and were tracked for more than three years. Throughout the trial, a total of 833 participants died with 58 per cent of the deaths related to cardiovascular causes and 42 per cent to others.
Bu hikaye The Independent dergisinin September 01, 2024 sayısından alınmıştır.
Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 9,000+ magazines and newspapers.
Already a subscriber ? Giriş Yap
Bu hikaye The Independent dergisinin September 01, 2024 sayısından alınmıştır.
Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 9,000+ magazines and newspapers.
Already a subscriber? Giriş Yap
Joshua is 'willing to die' in Wembley battle of Britain
Anthony Joshua has insisted that he is ready to “give everything to be victorious” against Daniel Dubois on Saturday, as the Britons clash at Wembley Stadium.
City's man for all occasions.could be named world No 1
Rodri may be first defensive midfielder to win Ballon d'Or
Liverpool overcome poor start to beat Milan in style
Another first for Arne Slot at Liverpool, and one that was much more significant than a debut win in this new Champions League.
Guardian parent company in talks to sell Observer
The Guardian Media Group (GMG) is in talks to sell The Observer newspaper to Tortoise Media, a news business launched in 2019 by a former BBC executive. The media giant is in exclusive discussions to sell the world's oldest Sunday newspaper.
'People can have a fantastic.second act. I'm living mine'
Actor and comic Omid Djalili is back for a fiery new stand-up tour. He tells Helen Coffey how he managed to channel rage into humour and why he's not leaving comedy to the young
Islamist party makes shock return to Kashmiri politics
Observers split on motivation of Jamaat-e-Islami, banned under terror laws and which boycotted elections for 30 years
US rapper charged with sex trafficking and racketeering
Sean \"Diddy\" Combs, the rapper and music mogul who has faced allegations of sexual abuse, was charged with racketeering, sex trafficking and transportation to engage in prostitution, according to a federal indictment unsealed yesterday.
Suspect in Trump shooting lurked for hours in bushes
The gunman accused of trying to assassinate Donald Trump hid in the bushes of the former president's Florida golf club for almost 12 hours, according to officials.
'I am a rapist', says husband of sexually abused woman
A French man accused of drugging his wife and recruiting dozens of strangers to rape her over a decade has declared in court: “I am a rapist, like everyone else in this courtroom.”
Hezbollah vows to retaliate after pager attack kills nine
Officials in Lebanon and Syria blame Israel for the explosions